Kolexia
Poupon Raoul
Gastro-entérologie
Cabinet libéral
Neuilly-sur-Seine, France
106 Activités
299 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cirrhose biliaire Fibrose Angiocholite Maladies du foie Cirrhose du foie Cholestase Angiocholite sclérosante Hépatite Lithiase biliaire

Industries

ADVANZ PHARMA FRANCE
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

BEZURSO: Multicenter, Randomized, Double-blind Placebo Controlled Trial of Bezafibrate for the Treatment of Primary Biliary Cirrhosis in Patients With Incomplete Response to Ursodesoxycholic Acid Therapy.
Essai Clinique (Assistance publique – Hôpitaux de Paris)   23 février 2023
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities.
JHEP reports : innovation in hepatology   06 novembre 2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
Journal of hepatology   17 septembre 2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Journal of hepatology   07 avril 2020
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC): Double-blind, Randomised, Placebo-controlled, Multi-centre Phase III Clinical Study Comparing the Combination of Ursodeoxycholic Acid Capsules Plus Budesonide Capsules to Ursodeoxycholic Acid Capsules Plus Placebo in the Treatment of Primary Biliary Cirrhosis
Essai Clinique (Dr. Falk Pharma GmbH)   27 janvier 2020
Déficits de synthèse des acides biliaires primaires
HAS Publications   27 novembre 2019
New treatments/targets for primary biliary cholangitis.
JHEP reports : innovation in hepatology   09 août 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   04 janvier 2019
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
Gastroenterology   06 octobre 2018
Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis.
Gut   18 septembre 2018